Secondary Logo

Journal Logo

Are New β-Lactam/β-Lactamase Inhibitors Viable Carbapenem Sparing Options for Treating Serious Infections Caused by Extended-Spectrum β-Lactamase-Producing Microorganisms?

Kallstrom, George; Written as an editorial commentary regarding Hatem Amer et al. Comparative Study Between ß-Lactam/ß-Lactamase Inhibitors as Alternatives for Carbapene

Infectious Diseases in Clinical Practice. 27(3):121-122, May 2019.

Disseminated Leishmaniasis With Immune Reconstitution Inflammatory Syndrome–associated Pneumocystis Pneumonia in a Human Immunodeficiency Virus–infected Patient With First-line Antiretroviral Therapy Failure

Gupta, Pulin Kumar; Mahto, Subodh Kumar; Mittal, Abhishek; More

Infectious Diseases in Clinical Practice. 27(3):e8-e10, May 2019.